BJDX Stock Summary and Trading Ideas (Bluejay Diagnostics | NASDAQ:BJDX)

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Bluejay Diagnostics trades on the NASDAQ stock market under the symbol BJDX.

As of August 20, 2026, BJDX stock price declined to $0.93 with 77,202 million shares trading.

BJDX has a beta of -1.99, meaning it tends to be less sensitive to market movements. BJDX has a correlation of 0.02 to the broad based SPY ETF.

BJDX has a market cap of $962,285.00. This is considered a Sub-Micro Cap stock.

In the last 3 years, BJDX traded as high as $13,120.00 and as low as $.83.

BJDX has underperformed the market in the last year with a price return of -82.1% while the SPY ETF gained +20.7%. BJDX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.6% and -25.0%, respectively, while the SPY returned +4.5% and -0.6%, respectively.

BJDX support price is $.87 and resistance is $1.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BJDX shares will trade within this expected range on the day.